Search results
Feb 3, 2021 · Janet Woodcock — often referred to as “the top drug cop” — had been in charge of CEDR for only a year in 1995 when the FDA considered approving OxyContin for sale to the public. Purdue ...
Jun 15, 2022 · OxyContin Decision Involved FDA ‘Miscalculation,’ Woodcock Says. A top FDA official who oversaw the approval of Purdue Pharma ‘s OxyContin said Wednesday that the agency failed to adequately predict the harms associated with the drug that has fallen into the center of the US opioid epidemic. Janet Woodcock, now the Food and Drug ...
- ccastronuovo@bloombergindustry.com
- Reporter
Feb 23, 2021 · Ed Bisch, whose 18-year-old son, Eddie, died of an OxyContin-related overdose in 2001. Credit... Hannah Yoon for The New York Times. Share full article. ... Dr. Janet Woodcock, long known as the ...
Jan 28, 2021 · Dr Janet Woodcock is accused of presiding over ‘one of the worst regulatory agency failures’, say groups fighting opioid epidemic Chris McGreal Thu 28 Jan 2021 12.18 EST Last modified on Thu ...
Feb 4, 2021 · Janet Woodcock is acting head of the FDA, ... controversial decisions undertaken during Dr Woodcock’s first period as head of the CDER was the 1995 approval of OxyContin, the powerful ...
Sep 14, 2021 · One person who appears consistently throughout this regulatory fiasco is Janet Woodcock, the FDA’s current acting commissioner. Woodcock was head of the FDA division that approved the initial OxyContin application in 1994 and held the position during a period in which the FDA approved a steady stream of other extended-release opioids.
Nov 26, 2009 · Author: Janet Woodcock, M.D. Author Info & Affiliations. Published November 26, 2009. N Engl J Med 2009; ... 65,000 for nonmedical use of oxycodone or oxycodone combinations, ...
